Lincoln Pharma Q1 results: Net profit up 20% at Rs 15 crore

Consolidated total income of the company stood at Rs 105.59 crore for the quarter under consideration. It was Rs 98.10 crore for the same period a year ago, it added.

By PTI | Updated: Aug 20, 2020, 07.28 PM IST

Promoters held 60 per cent stake in the company as of June 30, 2020, while FIIs held 3.6 per cent, DIIs 4.6 per cent and public and others 31.8 per cent.

NEW DELHI: Drug firm Lincoln Pharmaceuticals on Thursday reported a 20.44 per cent rise in its consolidated net profit to Rs 15.26 crore for the quarter ended June 30, 2020. The company had posted a net profit of Rs 12.67 crore for the corresponding period of the previous fiscal, Lincoln Pharmaceuticals said in a filing to BSE.

Consolidated total income of the company stood at Rs 105.59 crore for the quarter under consideration. It was Rs 98.10 crore for the same period a year ago, it added.

"Despite a challenging economic and business environment due to Covid-19, the company has delivered a robust financial performance quarter over quarter maintaining healthy growth in revenue, profitability and expects to continue the growth momentum in the coming years," Lincoln Pharmaceuticals MD, Mahendra Patel said.

Not making enough money in stocks? Click here for real-life stories of successful investors.

Too busy to trade in stocks? Invest in Mutual Funds with ET Money!